修身堂(08200.HK)首財季虧損減少約56%至302.6萬港元
格隆匯 8 月 11日丨修身堂(08200.HK)發佈公告,截至2020年6月30日止三個月,集團的收益約達2.88億港元,較去年同期上升約16%。主要歸因於上海東紡日化銷售有限公司於本回顧期間的分銷銷售增加至約2.71億港元(2019年:約2.25億港元)。
回顧期間內,毛利約為2598.3萬港元,較去年同期減少約19%。減少主要由於提供美容及纖體服務以及銷售保健、美容及相關產品所產生的收益減少,部分減少被東紡分銷銷售帶來的收益增加及證券投資所產生的正面回報所抵銷。加上致力控制營運成本及獲得政府的防疫抗疫基金資助,集團錄得公司擁有人應占虧損約302.6萬港元,較去年同期約685萬港元減少約56%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.